20th Canadian Collaborative Mental Health Care Conference

20th Canadian Collaborative Mental Health Care Conference

Target Audience:

Interprofessional/intersectoral teams, family physicians and other primary care providers, mental health care providers, psychiatrists and psychologists, administrators and policy makers, other health disciplines working with primary care and/or community care, consumers and family members, educators and their students, and researchers.

Course Format: Multiple small group sessions with keynote presenters
  • May 10, 2019 to May 11, 2019
Sheraton Vancouver Airport Hotel
7551 Westminster Hwy
Richmond
Full-Sized Map

Overview

Call for abstracts is now open! Click here to download the 2019 abstract guidelines.

Please note that you can make edits to the abstracts up until the cut off date has been extended until Jan 6 2019. Notifications will be ready by early February 2019.

OVERVIEW

The Canadian Collaborative Mental Health Care Conference aims to advance collaborative practice in mental health care in primary care and community settings. Our scope includes intra- and interprofessional collaboration, as well as collaboration with clients and caregivers. We value multiple forms of knowledge and ‘evidence’ including scientific knowledge, pragmatic knowledge of front line healthcare providers and administrators, and experiential knowledge of people using mental health  services, and throughout the conference we seek to promote dialogue between these different perspectives.

This year our conference theme addresses concurrent disorders  and working collaboratively to enhance care for people living with mental health challenges &  addictions . A concurrent disorder is defined as having both a mental health issue and an addiction issue at the same time. Traditionally our health systems have separated mental illness and addiction and therefore two treatment streams have emerged. We now recognize that these two “streams” are intimately tied together and we need to address our clients and families in a holistic way seamlessly collaborating across disciplines, organizations and cultures. North America is facing an opioid crisis and more than ever, we need to work together to understand the underpinnings of concurrent disorders and their impacts on patients, families and communities, create collaborative health care systems and    embrace innovation. We invite you to submit an abstract and attend the conference to share the work you and your team have been doing in collaborative care.

Key Speakers

Dr. Patricia Conrod, Ph.D. Professor at the Université of Montréal, Department of Psychiatry. The personality-targeted approach to treating substance use problems was first developed and tested by Dr. Patricia Conrod at McGill University in Montreal, Canada (1995-2000). For more info on Dr. Conrod's work click here.

Dr. Anna Ratzliff MD, PhD. is a national expert on collaborative care and specifically, on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine.  She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training, mental health workforce development, adult learning best practices, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions), is the Director of the UW Integrated Care Training Program for residents and fellows, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center Website (aims.uw.edu), the UW Integrated Care Training Program (ictp.uw.edu).

Dr. Cornelia (Nel) Wieman,MD, FRCPC. President, The Indigenous Physicians Association of Canada. Is Canada’s first female Indigenous psychiatrist (Anishnawbe – Little Grand Rapids First Nation, Manitoba). In January 2018, Nel joined the First Nations Health Authority in BC as a Senior Medical Officer, Mental Health & Wellness, in the FNHA’s Office of the Chief Medical Officer. From 2013-2018, she was a staff psychiatrist at the Centre for Addictions and Mental Health (CAMH) in Toronto, in CAMH’s Aboriginal Services Unit, Tele-psychiatry Service (Northern Psychiatric Outreach Program), Crisis Clinic and General Assessment Clinic. Since 2016, Nel has also served as the Faculty Advisor to the Indigenous Students’ Health Sciences Office at McMaster University. Prior to this, Nel was a member of the Clinical Support Team at YWCA Toronto’s Elm Centre providing psychiatric services to over 100 women living with serious mental illness and addictions, and was a special consultant to the Chief Public Health Officer of the Public Health Agency of Canada. From 2004-2011, she was the Co-Director of the Indigenous Health Research Development Program and an Assistant Professor in the Dalla Lana School of Public Health, Faculty of Medicine at the University of Toronto. Nel began her career by providing psychiatric services at the community mental health clinic on Six Nations of the Grand River Territory (1997-2005) after completing her medical degree (1993) and while completing her psychiatry specialty training (1998) at McMaster University in Hamilton, Ontario. In February 2013, Nel was awarded the Queen Elizabeth II Diamond Jubilee Medal.

Dr. Evan Wood, MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat. Director of the British Columbia Centre on Substance Use based at St. Paul’s Hospital in Vancouver. He is also a professor of medicine at the University of British Columbia, where he helps lead the university’s efforts in the area of addiction prevention and treatment through a Tier 1 Canada Research Chair. Dr. Wood is a general internal medicine specialist and diplomate of the American Board of Addiction Medicine who has been responsible for the creation of a number of addiction clinical and clinical training programs.  His research is funded by the U.S. National Institute on Drug Abuse and CIHR through the Canadian Research Initiative on Substance Misuse.

Accommodation

Sheraton Vancouver Airport Hotel
7551 Westminster Hwy
Richmond  British Columbia  V6X1A3
Canada

Special conference rates starting at $199 CDN per night are offered to conference attendees. If calling please reference the group code CE09AD or else use the special hotel booking link below to register online.  In order to take advantage of the special conference rate, reservations must be made by 5PM PST on April 9, 2019.


 

T: 1-800-663-0299
Top
More »